ArticleJCI insight2017
Rilonacept maintains long-term inflammatory remission in patients with deficiency of the IL-1 receptor antagonist.
Megha Garg et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this paperpooled itcites it